A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer

NCT01004250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Bevacizumab

Sponsor

Eli Lilly and Company